Abiopharma

News list

📋 Christopher Sarchi (Officer) plans to sell 18K shares of Replimune Group Inc. (at $7.70 each, total $142K) Filed: Apr 02, 2026 | ID: 000348

Full text

News bot April 2, 2026, 8:16 p.m.
📋 Form 144 Filing: Christopher Sarchi

Company: Replimune Group Inc.

Filing Date: 2026-04-02

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 18,500
- Price per Share: $7.70
- Total Value: $142,450.00
- Planned Sale Date: 2026-04-02
- Broker: J.P. Morgan Securities LLC
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-38596
- Issuer Contact Phone: 7812229600
- Issuer Address: 500 Unicorn Park Drive, Suite 303, Woburn, MA, 01801
- Broker Address: 270 Park Avenue, 10th Floor, New York, NY, 10017
- Shares Outstanding: 82572619.0
- Number of Securities to be Sold: 3
- Signature: /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Christopher Sarchi.
- Plan Adoption Dates: 2025-12-15